Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.
2.
3.

The mechanisms of action of nicotinamide and zinc in inflammatory skin disease.

Fivenson DP.

Cutis. 2006 Jan;77(1 Suppl):5-10. Review.

PMID:
16871773
4.

Nicotinamide and the skin.

Chen AC, Damian DL.

Australas J Dermatol. 2014 Aug;55(3):169-75. doi: 10.1111/ajd.12163. Epub 2014 Mar 17. Review.

PMID:
24635573
5.

New antibiotic therapies for acne and rosacea.

Mays RM, Gordon RA, Wilson JM, Silapunt S.

Dermatol Ther. 2012 Jan-Feb;25(1):23-37. doi: 10.1111/j.1529-8019.2012.01497.x.

PMID:
22591497
6.

A review of nicotinamide: treatment of skin diseases and potential side effects.

Rolfe HM.

J Cosmet Dermatol. 2014 Dec;13(4):324-8. doi: 10.1111/jocd.12119. Review.

PMID:
25399625
7.

A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.

McHugh RC, Rice A, Sangha ND, McCarty MA, Utterback R, Rohrback JM, Osborne BE, Fleischer AB Jr, Feldman SR.

J Dermatolog Treat. 2004 Sep;15(5):295-302.

PMID:
15370397
8.

Recently approved systemic therapies for acne vulgaris and rosacea.

Del Rosso JQ.

Cutis. 2007 Aug;80(2):113-20. Review. Erratum in: Cutis. 2007 Oct;80(4):334.

PMID:
17944168
9.

Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris.

Shalita AR, Smith JG, Parish LC, Sofman MS, Chalker DK.

Int J Dermatol. 1995 Jun;34(6):434-7.

PMID:
7657446
10.

Antibiotic use in acne vulgaris and rosacea: clinical considerations and resistance issues of significance to dermatologists.

Del Rosso JQ, Leyden JJ, Thiboutot D, Webster GF.

Cutis. 2008 Aug;82(2 Suppl 2):5-12. Review.

PMID:
18924545
11.

Tetracyclines: nonantibiotic properties and their clinical implications.

Sapadin AN, Fleischmajer R.

J Am Acad Dermatol. 2006 Feb;54(2):258-65. Review.

PMID:
16443056
13.

Subantimicrobial dose doxycycline for acne and rosacea.

Bikowski JB.

Skinmed. 2003 Jul-Aug;2(4):234-45. Review.

PMID:
14673277
14.

Inflammation in rosacea and acne: Implications for patient care.

Fleischer AB Jr.

J Drugs Dermatol. 2011 Jun;10(6):614-20. Review.

PMID:
21961194
16.

Emerging drugs for acne.

James KA, Burkhart CN, Morrell DS.

Expert Opin Emerg Drugs. 2009 Dec;14(4):649-59. doi: 10.1517/14728210903251690. Review.

PMID:
19772370
17.

Minocycline for acne vulgaris: efficacy and safety.

Garner SE, Eady EA, Popescu C, Newton J, Li WA.

Cochrane Database Syst Rev. 2003;(1):CD002086. Review. Update in: Cochrane Database Syst Rev. 2012;8:CD002086.

PMID:
12535427
18.

Minocycline for acne vulgaris: efficacy and safety.

Garner SE, Eady EA, Popescu C, Newton J, Li Wan Po A.

Cochrane Database Syst Rev. 2000;(2):CD002086. Review. Update in: Cochrane Database Syst Rev. 2003;(1):CD002086.

PMID:
10796856
19.
20.

[Oxytetracycline--mechanism of action and application in skin diseases].

Olszewska M.

Wiad Lek. 2006;59(11-12):829-33. Review. Polish.

PMID:
17427500

Supplemental Content

Support Center